+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Hydrolase Market - Global Forecast 2026-2032

  • Report

  • 195 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6282533
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Hydrolase Market Executive Summary: Scope and Strategic Context

Hydrolases are enzymes that catalyze the cleavage of chemical bonds through the addition of water. They are used across biocatalysis, food processing, pharmaceuticals, diagnostics, biotechnology, detergents, agriculture, and environmental applications. The market is shaped by demand for selective, lower-temperature, and potentially less resource-intensive processing, alongside continued advances in enzyme discovery, formulation, stabilization, and immobilization.

Transformative Shifts Reshaping Hydrolase Development and Use

Hydrolase development is moving from broad activity screening toward application-specific performance engineering. Greater attention is being given to thermostability, solvent tolerance, pH range, substrate selectivity, recyclability, and compatibility with continuous processing. Advances in protein engineering, metagenomic discovery, fermentation, immobilization, and downstream purification are expanding the practical range of hydrolases in industrial and laboratory settings. Regulatory scrutiny, reproducibility requirements, supply-chain resilience, and demand for cleaner manufacturing are also influencing product design and procurement decisions.

How Artificial Intelligence Is Accelerating Hydrolase Innovation

Artificial intelligence is contributing to hydrolase research by helping scientists prioritize candidate sequences, predict structure and function, identify mutation targets, and optimize experimental workflows. Machine-learning models can integrate sequence, structural, reaction, and process data to support improved enzyme engineering and formulation decisions. The strongest value is achieved when computational predictions are combined with high-quality assays, transparent validation, and process-specific testing. Data quality, interpretability, intellectual-property protection, and laboratory reproducibility remain important constraints to responsible adoption.

Regional Hydrolase Insights Across Established and Emerging Biocatalysis Hubs

North America benefits from strong biotechnology research capacity, pharmaceutical development, and industrial enzyme applications. Europe emphasizes sustainable chemistry, regulatory compliance, circular manufacturing, and bio-based processing, with the European Union supporting collaborative innovation frameworks. Asia-Pacific combines major pharmaceutical, food, textile, detergent, and fermentation industries with expanding research capabilities, particularly across China, Japan, India, South Korea, and Australia. Latin America presents opportunities linked to agricultural processing, food production, biofuels, and local biotechnology development. The Middle East is prioritizing advanced manufacturing, water-related applications, and economic diversification, while Africa’s opportunities are closely connected to food security, agricultural value chains, public-health laboratories, and capacity building.

Hydrolase Priorities Across ASEAN, BRICS, EU, G7, GCC, and NATO

ASEAN economies can leverage hydrolases in food, palm-based processing, aquaculture, agriculture, and expanding biomanufacturing systems. BRICS members bring substantial agricultural, pharmaceutical, chemical, and research capabilities, but infrastructure and regulatory conditions vary widely. The European Union is focused on sustainability, safety, and cross-border research coordination. G7 economies contribute advanced life-science research, industrial automation, and quality systems, while GCC countries are developing biotechnology and manufacturing capabilities alongside food and water-security priorities. NATO members collectively offer deep research and industrial networks, although procurement, biosafety, and strategic-resilience priorities can differ across jurisdictions.

Country-Level Hydrolase Dynamics in Fifteen Priority Markets

Australia is positioned around biotechnology research, agriculture, food processing, and environmental applications. Brazil and Mexico have opportunities in food, agriculture, biofuels, and industrial biotechnology. Canada combines academic research, bioprocessing, and resource-sector applications. China and India offer broad manufacturing, pharmaceutical, food, and enzyme-engineering ecosystems. France, Germany, Italy, Spain, and the United Kingdom maintain strong capabilities in industrial biotechnology, food science, pharmaceuticals, and sustainable chemistry. Japan and South Korea emphasize precision manufacturing, advanced materials, food technology, and biopharmaceutical research. Russia retains relevant scientific and industrial capabilities, while infrastructure access, trade conditions, and research collaboration affect deployment pathways. The United States remains a major center for enzyme discovery, biopharmaceutical innovation, industrial biotechnology, and computational protein engineering.

Actionable Priorities for Hydrolase Industry Leaders

Leaders should define enzyme performance around the complete process rather than activity alone, measuring stability, selectivity, recovery, downstream effects, and total operating requirements. They should build partnerships spanning computational design, strain development, formulation, equipment, and end-user validation. Portfolio resilience can be improved through diversified biological sources, manufacturing routes, qualified suppliers, and regional technical support. Companies should also establish robust data governance for AI-enabled discovery, validate claims under realistic process conditions, and align development plans with local safety, labeling, environmental, and regulatory expectations.

Research Methodology for the Hydrolase Executive Summary

This executive summary uses a structured qualitative approach grounded in the supplied market scope and established characteristics of hydrolase technologies. It synthesizes application domains, enabling technologies, regional industrial conditions, country-level capabilities, and organizational groupings relevant to enzyme development and use. Insights are framed as documented technology and industry patterns rather than market estimates. The analysis excludes market sizing, market shares, forecasts, and company-specific claims, and emphasizes verifiable mechanisms, applications, capabilities, and strategic considerations.

Conclusion: Building Durable Advantage in Hydrolase Applications

Hydrolases remain important tools for selective bond cleavage across life sciences, manufacturing, food, consumer products, and environmental processing. Competitive progress will depend on translating advances in discovery and artificial intelligence into enzymes that perform reliably under real operating conditions. Organizations that combine rigorous validation, scalable bioprocessing, responsible data practices, regional regulatory awareness, and application-focused partnerships will be better positioned to convert hydrolase innovation into durable operational value.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Hydrolase Market, by Enzyme Type
7.1. Introduction
7.2. Proteases / Peptidases
7.3. Lipases
7.4. Amylases and glycosidases
7.5. Cellulases and hemicellulases
7.6. Esterases and phosphatases
8. Hydrolase Market, by Source / Production Method
8.1. Introduction
8.2. Microbial hydrolases
8.3. Plant-derived hydrolases
8.4. Animal-derived hydrolases
9. Hydrolase Market, by Formulation and Form
9.1. Introduction
9.2. Liquid enzyme preparations
9.3. Granular / powder enzymes
9.4. Immobilized hydrolases
10. Hydrolase Market, by Application
10.1. Introduction
10.2. Food and beverages
10.3. Pharmaceuticals and healthcare
10.3.1. Digestive-enzyme supplements
10.3.2. Therapeutic proteases
10.3.3. Diagnostic enzymes
10.4. Laundry and household detergents
10.5. Textile and leather processing
10.6. Pulp, paper, and biofuel
11. Hydrolase Market, by End User
11.1. Introduction
11.2. Direct Sales
11.3. Distributor and channel sales
12. Hydrolase Market, by Region
12.1. Introduction
12.2. Asia-Pacific
12.3. North America
12.4. Latin America
12.5. Europe
12.6. Middle East
12.7. Africa
13. Hydrolase Market, by Group
13.1. Introduction
13.2. ASEAN
13.3. GCC
13.4. European Union
13.5. BRICS
13.6. G7
13.7. NATO
14. Hydrolase Market, by Country
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. United Kingdom
14.7. Germany
14.8. France
14.9. Russia
14.10. Italy
14.11. Spain
14.12. China
14.13. India
14.14. Japan
14.15. Australia
14.16. South Korea
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. Market Concentration Analysis, 2025
15.2.1. Concentration Ratio (CR)
15.2.2. Herfindahl Hirschman Index (HHI)
15.3. Recent Developments & Impact Analysis, 2025
15.4. Product Portfolio Analysis, 2025
15.5. Benchmarking Analysis, 2025
16. Company Profiles
16.1. AB Enzymes GmbH
16.2. ABF Ingredients
16.3. Advanced Enzyme Technologies Ltd.
16.4. Amano Enzyme Inc.
16.5. Archer-Daniel Midland Company
16.6. AstraZeneca plc
16.7. BASF SE
16.8. Bayer AG
16.9. Chr. Hansen Holding A/S
16.10. DSM N.V.
16.11. DuPont de Nemours, Inc.
16.12. Enzyme Development Corporation
16.13. Genencor
16.14. GlaxoSmithKline plc
16.15. Hangzhou Tianyuan Biochemical Co., Ltd.
16.16. InVitro International LLC
16.17. Kerry Group plc
16.18. Kingenta Ecological Engineering Group Co., Ltd.
16.19. Novozymes A/S
16.20. Novus International, Inc.
16.21. Pfizer Inc.
16.22. Puratos Group NV
16.23. Shandong Longda Biotechnology Co., Ltd.
16.24. Syngenta AG
16.25. Tate & Lyle PLC
17. Key Experts
LIST OF FIGURES
FIGURE 1. Global Hydrolase Market, Years Considered for the Study
FIGURE 2. Global Hydrolase Market, Research Design
FIGURE 3. Global Hydrolase Market, Research Framework
FIGURE 4. Global Hydrolase Market, Data Triangulation
FIGURE 5. Global Hydrolase Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Hydrolase Market Size, by Enzyme Type, 2025 vs 2032 (%)
FIGURE 7. Global Hydrolase Market Size, by Enzyme Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Hydrolase Market Size, by Source / Production Method, 2025 vs 2032 (%)
FIGURE 9. Global Hydrolase Market Size, by Source / Production Method, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Hydrolase Market Size, by Formulation and Form, 2025 vs 2032 (%)
FIGURE 11. Global Hydrolase Market Size, by Formulation and Form, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Hydrolase Market Size, by Application, 2025 vs 2032 (%)
FIGURE 13. Global Hydrolase Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Hydrolase Market Size, by End User, 2025 vs 2032 (%)
FIGURE 15. Global Hydrolase Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Hydrolase Market Size, by Region, 2025 vs 2032 (%)
FIGURE 17. Global Hydrolase Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Hydrolase Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Hydrolase Market Size, by Country, 2025 vs 2032 (%)
FIGURE 20. Global Hydrolase Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global Hydrolase Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Hydrolase Market Segmentation & Coverage
TABLE 2. Global Hydrolase Market Size, 2017-2032 (USD Million)
TABLE 3. Global Hydrolase Market Size, by Enzyme Type, 2017-2032 (USD Million)
TABLE 4. Global Proteases / Peptidases Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Proteases / Peptidases Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Proteases / Peptidases Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Lipases Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Lipases Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Lipases Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Amylases and glycosidases Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Amylases and glycosidases Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Amylases and glycosidases Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Cellulases and hemicellulases Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Cellulases and hemicellulases Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Cellulases and hemicellulases Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Esterases and phosphatases Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Esterases and phosphatases Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Esterases and phosphatases Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Hydrolase Market Size, by Source / Production Method, 2017-2032 (USD Million)
TABLE 20. Global Microbial hydrolases Market Size, by Region, 2017-2032 (USD Million)
TABLE 21. Global Microbial hydrolases Market Size, by Group, 2017-2032 (USD Million)
TABLE 22. Global Microbial hydrolases Market Size, by Country, 2017-2032 (USD Million)
TABLE 23. Global Plant-derived hydrolases Market Size, by Region, 2017-2032 (USD Million)
TABLE 24. Global Plant-derived hydrolases Market Size, by Group, 2017-2032 (USD Million)
TABLE 25. Global Plant-derived hydrolases Market Size, by Country, 2017-2032 (USD Million)
TABLE 26. Global Animal-derived hydrolases Market Size, by Region, 2017-2032 (USD Million)
TABLE 27. Global Animal-derived hydrolases Market Size, by Group, 2017-2032 (USD Million)
TABLE 28. Global Animal-derived hydrolases Market Size, by Country, 2017-2032 (USD Million)
TABLE 29. Global Hydrolase Market Size, by Formulation and Form, 2017-2032 (USD Million)
TABLE 30. Global Liquid enzyme preparations Market Size, by Region, 2017-2032 (USD Million)
TABLE 31. Global Liquid enzyme preparations Market Size, by Group, 2017-2032 (USD Million)
TABLE 32. Global Liquid enzyme preparations Market Size, by Country, 2017-2032 (USD Million)
TABLE 33. Global Granular / powder enzymes Market Size, by Region, 2017-2032 (USD Million)
TABLE 34. Global Granular / powder enzymes Market Size, by Group, 2017-2032 (USD Million)
TABLE 35. Global Granular / powder enzymes Market Size, by Country, 2017-2032 (USD Million)
TABLE 36. Global Immobilized hydrolases Market Size, by Region, 2017-2032 (USD Million)
TABLE 37. Global Immobilized hydrolases Market Size, by Group, 2017-2032 (USD Million)
TABLE 38. Global Immobilized hydrolases Market Size, by Country, 2017-2032 (USD Million)
TABLE 39. Global Hydrolase Market Size, by Application, 2017-2032 (USD Million)
TABLE 40. Global Food and beverages Market Size, by Region, 2017-2032 (USD Million)
TABLE 41. Global Food and beverages Market Size, by Group, 2017-2032 (USD Million)
TABLE 42. Global Food and beverages Market Size, by Country, 2017-2032 (USD Million)
TABLE 43. Global Pharmaceuticals and healthcare Market Size, by Region, 2017-2032 (USD Million)
TABLE 44. Global Pharmaceuticals and healthcare Market Size, by Group, 2017-2032 (USD Million)
TABLE 45. Global Pharmaceuticals and healthcare Market Size, by Country, 2017-2032 (USD Million)
TABLE 46. Global Digestive-enzyme supplements Market Size, by Region, 2017-2032 (USD Million)
TABLE 47. Global Digestive-enzyme supplements Market Size, by Group, 2017-2032 (USD Million)
TABLE 48. Global Digestive-enzyme supplements Market Size, by Country, 2017-2032 (USD Million)
TABLE 49. Global Therapeutic proteases Market Size, by Region, 2017-2032 (USD Million)
TABLE 50. Global Therapeutic proteases Market Size, by Group, 2017-2032 (USD Million)
TABLE 51. Global Therapeutic proteases Market Size, by Country, 2017-2032 (USD Million)
TABLE 52. Global Diagnostic enzymes Market Size, by Region, 2017-2032 (USD Million)
TABLE 53. Global Diagnostic enzymes Market Size, by Group, 2017-2032 (USD Million)
TABLE 54. Global Diagnostic enzymes Market Size, by Country, 2017-2032 (USD Million)
TABLE 55. Global Laundry and household detergents Market Size, by Region, 2017-2032 (USD Million)
TABLE 56. Global Laundry and household detergents Market Size, by Group, 2017-2032 (USD Million)
TABLE 57. Global Laundry and household detergents Market Size, by Country, 2017-2032 (USD Million)
TABLE 58. Global Textile and leather processing Market Size, by Region, 2017-2032 (USD Million)
TABLE 59. Global Textile and leather processing Market Size, by Group, 2017-2032 (USD Million)
TABLE 60. Global Textile and leather processing Market Size, by Country, 2017-2032 (USD Million)
TABLE 61. Global Pulp, paper, and biofuel Market Size, by Region, 2017-2032 (USD Million)
TABLE 62. Global Pulp, paper, and biofuel Market Size, by Group, 2017-2032 (USD Million)
TABLE 63. Global Pulp, paper, and biofuel Market Size, by Country, 2017-2032 (USD Million)
TABLE 64. Global Hydrolase Market Size, by End User, 2017-2032 (USD Million)
TABLE 65. Global Direct Sales Market Size, by Region, 2017-2032 (USD Million)
TABLE 66. Global Direct Sales Market Size, by Group, 2017-2032 (USD Million)
TABLE 67. Global Direct Sales Market Size, by Country, 2017-2032 (USD Million)
TABLE 68. Global Distributor and channel sales Market Size, by Region, 2017-2032 (USD Million)
TABLE 69. Global Distributor and channel sales Market Size, by Group, 2017-2032 (USD Million)
TABLE 70. Global Distributor and channel sales Market Size, by Country, 2017-2032 (USD Million)
TABLE 71. Global Hydrolase Market Size, by Region, 2017-2032 (USD Million)
TABLE 72. Asia-Pacific Hydrolase Market Size, by Region, 2017-2032 (USD Million)
TABLE 73. Asia-Pacific Hydrolase Market Size, by Enzyme Type, 2017-2032 (USD Million)
TABLE 74. Asia-Pacific Hydrolase Market Size, by Source / Production Method, 2017-2032 (USD Million)
TABLE 75. Asia-Pacific Hydrolase Market Size, by Formulation and Form, 2017-2032 (USD Million)
TABLE 76. Asia-Pacific Hydrolase Market Size, by Application, 2017-2032 (USD Million)
TABLE 77. Asia-Pacific Hydrolase Market Size, by Pharmaceuticals and healthcare, 2017-2032 (USD Million)
TABLE 78. Asia-Pacific Hydrolase Market Size, by End User, 2017-2032 (USD Million)
TABLE 79. North America Hydrolase Market Size, by Region, 2017-2032 (USD Million)
TABLE 80. North America Hydrolase Market Size, by Enzyme Type, 2017-2032 (USD Million)
TABLE 81. North America Hydrolase Market Size, by Source / Production Method, 2017-2032 (USD Million)
TABLE 82. North America Hydrolase Market Size, by Formulation and Form, 2017-2032 (USD Million)
TABLE 83. North America Hydrolase Market Size, by Application, 2017-2032 (USD Million)
TABLE 84. North America Hydrolase Market Size, by Pharmaceuticals and healthcare, 2017-2032 (USD Million)
TABLE 85. North America Hydrolase Market Size, by End User, 2017-2032 (USD Million)
TABLE 86. Latin America Hydrolase Market Size, by Region, 2017-2032 (USD Million)
TABLE 87. Latin America Hydrolase Market Size, by Enzyme Type, 2017-2032 (USD Million)
TABLE 88. Latin America Hydrolase Market Size, by Source / Production Method, 2017-2032 (USD Million)
TABLE 89. Latin America Hydrolase Market Size, by Formulation and Form, 2017-2032 (USD Million)
TABLE 90. Latin America Hydrolase Market Size, by Application, 2017-2032 (USD Million)
TABLE 91. Latin America Hydrolase Market Size, by Pharmaceuticals and healthcare, 2017-2032 (USD Million)
TABLE 92. Latin America Hydrolase Market Size, by End User, 2017-2032 (USD Million)
TABLE 93. Europe Hydrolase Market Size, by Region, 2017-2032 (USD Million)
TABLE 94. Europe Hydrolase Market Size, by Enzyme Type, 2017-2032 (USD Million)
TABLE 95. Europe Hydrolase Market Size, by Source / Production Method, 2017-2032 (USD Million)
TABLE 96. Europe Hydrolase Market Size, by Formulation and Form, 2017-2032 (USD Million)
TABLE 97. Europe Hydrolase Market Size, by Application, 2017-2032 (USD Million)
TABLE 98. Europe Hydrolase Market Size, by Pharmaceuticals and healthcare, 2017-2032 (USD Million)
TABLE 99. Europe Hydrolase Market Size, by End User, 2017-2032 (USD Million)
TABLE 100. Middle East Hydrolase Market Size, by Region, 2017-2032 (USD Million)
TABLE 101. Middle East Hydrolase Market Size, by Enzyme Type, 2017-2032 (USD Million)
TABLE 102. Middle East Hydrolase Market Size, by Source / Production Method, 2017-2032 (USD Million)
TABLE 103. Middle East Hydrolase Market Size, by Formulation and Form, 2017-2032 (USD Million)
TABLE 104. Middle East Hydrolase Market Size, by Application, 2017-2032 (USD Million)
TABLE 105. Middle East Hydrolase Market Size, by Pharmaceuticals and healthcare, 2017-2032 (USD Million)
TABLE 106. Middle East Hydrolase Market Size, by End User, 2017-2032 (USD Million)
TABLE 107. Africa Hydrolase Market Size, by Region, 2017-2032 (USD Million)
TABLE 108. Africa Hydrolase Market Size, by Enzyme Type, 2017-2032 (USD Million)
TABLE 109. Africa Hydrolase Market Size, by Source / Production Method, 2017-2032 (USD Million)
TABLE 110. Africa Hydrolase Market Size, by Formulation and Form, 2017-2032 (USD Million)
TABLE 111. Africa Hydrolase Market Size, by Application, 2017-2032 (USD Million)
TABLE 112. Africa Hydrolase Market Size, by Pharmaceuticals and healthcare, 2017-2032 (USD Million)
TABLE 113. Africa Hydrolase Market Size, by End User, 2017-2032 (USD Million)
TABLE 114. Global Hydrolase Market Size, by Group, 2017-2032 (USD Million)
TABLE 115. ASEAN Hydrolase Market Size, by Group, 2017-2032 (USD Million)
TABLE 116. ASEAN Hydrolase Market Size, by Enzyme Type, 2017-2032 (USD Million)
TABLE 117. ASEAN Hydrolase Market Size, by Source / Production Method, 2017-2032 (USD Million)
TABLE 118. ASEAN Hydrolase Market Size, by Formulation and Form, 2017-2032 (USD Million)
TABLE 119. ASEAN Hydrolase Market Size, by Application, 2017-2032 (USD Million)
TABLE 120. ASEAN Hydrolase Market Size, by Pharmaceuticals and healthcare, 2017-2032 (USD Million)
TABLE 121. ASEAN Hydrolase Market Size, by End User, 2017-2032 (USD Million)
TABLE 122. GCC Hydrolase Market Size, by Group, 2017-2032 (USD Million)
TABLE 123. GCC Hydrolase Market Size, by Enzyme Type, 2017-2032 (USD Million)
TABLE 124. GCC Hydrolase Market Size, by Source / Production Method, 2017-2032 (USD Million)
TABLE 125. GCC Hydrolase Market Size, by Formulation and Form, 2017-2032 (USD Million)
TABLE 126. GCC Hydrolase Market Size, by Application, 2017-2032 (USD Million)
TABLE 127. GCC Hydrolase Market Size, by Pharmaceuticals and healthcare, 2017-2032 (USD Million)
TABLE 128. GCC Hydrolase Market Size, by End User, 2017-2032 (USD Million)
TABLE 129. European Union Hydrolase Market Size, by Group, 2017-2032 (USD Million)
TABLE 130. European Union Hydrolase Market Size, by Enzyme Type, 2017-2032 (USD Million)
TABLE 131. European Union Hydrolase Market Size, by Source / Production Method, 2017-2032 (USD Million)
TABLE 132. European Union Hydrolase Market Size, by Formulation and Form, 2017-2032 (USD Million)
TABLE 133. European Union Hydrolase Market Size, by Application, 2017-2032 (USD Million)
TABLE 134. European Union Hydrolase Market Size, by Pharmaceuticals and healthcare, 2017-2032 (USD Million)
TABLE 135. European Union Hydrolase Market Size, by End User, 2017-2032 (USD Million)
TABLE 136. BRICS Hydrolase Market Size, by Group, 2017-2032 (USD Million)
TABLE 137. BRICS Hydrolase Market Size, by Enzyme Type, 2017-2032 (USD Million)
TABLE 138. BRICS Hydrolase Market Size, by Source / Production Method, 2017-2032 (USD Million)
TABLE 139. BRICS Hydrolase Market Size, by Formulation and Form, 2017-2032 (USD Million)
TABLE 140. BRICS Hydrolase Market Size, by Application, 2017-2032 (USD Million)
TABLE 141. BRICS Hydrolase Market Size, by Pharmaceuticals and healthcare, 2017-2032 (USD Million)
TABLE 142. BRICS Hydrolase Market Size, by End User, 2017-2032 (USD Million)
TABLE 143. G7 Hydrolase Market Size, by Group, 2017-2032 (USD Million)
TABLE 144. G7 Hydrolase Market Size, by Enzyme Type, 2017-2032 (USD Million)
TABLE 145. G7 Hydrolase Market Size, by Source / Production Method, 2017-2032 (USD Million)
TABLE 146. G7 Hydrolase Market Size, by Formulation and Form, 2017-2032 (USD Million)
TABLE 147. G7 Hydrolase Market Size, by Application, 2017-2032 (USD Million)
TABLE 148. G7 Hydrolase Market Size, by Pharmaceuticals and healthcare, 2017-2032 (USD Million)
TABLE 149. G7 Hydrolase Market Size, by End User, 2017-2032 (USD Million)
TABLE 150. NATO Hydrolase Market Size, by Group, 2017-2032 (USD Million)
TABLE 151. NATO Hydrolase Market Size, by Enzyme Type, 2017-2032 (USD Million)
TABLE 152. NATO Hydrolase Market Size, by Source / Production Method, 2017-2032 (USD Million)
TABLE 153. NATO Hydrolase Market Size, by Formulation and Form, 2017-2032 (USD Million)
TABLE 154. NATO Hydrolase Market Size, by Application, 2017-2032 (USD Million)
TABLE 155. NATO Hydrolase Market Size, by Pharmaceuticals and healthcare, 2017-2032 (USD Million)
TABLE 156. NATO Hydrolase Market Size, by End User, 2017-2032 (USD Million)
TABLE 157. Global Hydrolase Market Size, by Country, 2017-2032 (USD Million)
TABLE 158. United States Hydrolase Market Size, 2017-2032 (USD Million)
TABLE 159. United States Hydrolase Market Size, by Enzyme Type, 2017-2032 (USD Million)
TABLE 160. United States Hydrolase Market Size, by Source / Production Method, 2017-2032 (USD Million)
TABLE 161. United States Hydrolase Market Size, by Formulation and Form, 2017-2032 (USD Million)
TABLE 162. United States Hydrolase Market Size, by Application, 2017-2032 (USD Million)
TABLE 163. United States Hydrolase Market Size, by Pharmaceuticals and healthcare, 2017-2032 (USD Million)
TABLE 164. United States Hydrolase Market Size, by End User, 2017-2032 (USD Million)
TABLE 165. Canada Hydrolase Market Size, 2017-2032 (USD Million)
TABLE 166. Canada Hydrolase Market Size, by Enzyme Type, 2017-2032 (USD Million)
TABLE 167. Canada Hydrolase Market Size, by Source / Production Method, 2017-2032 (USD Million)
TABLE 168. Canada Hydrolase Market Size, by Formulation and Form, 2017-2032 (USD Million)
TABLE 169. Canada Hydrolase Market Size, by Application, 2017-2032 (USD Million)
TABLE 170. Canada Hydrolase Market Size, by Pharmaceuticals and healthcare, 2017-2032 (USD Million)
TABLE 171. Canada Hydrolase Market Size, by End User, 2017-2032 (USD Million)
TABLE 172. Mexico Hydrolase Market Size, 2017-2032 (USD Million)
TABLE 173. Mexico Hydrolase Market Size, by Enzyme Type, 2017-2032 (USD Million)
TABLE 174. Mexico Hydrolase Market Size, by Source / Production Method, 2017-2032 (USD Million)
TABLE 175. Mexico Hydrolase Market Size, by Formulation and Form, 2017-2032 (USD Million)
TABLE 176. Mexico Hydrolase Market Size, by Application, 2017-2032 (USD Million)
TABLE 177. Mexico Hydrolase Market Size, by Pharmaceuticals and healthcare, 2017-2032 (USD Million)
TABLE 178. Mexico Hydrolase Market Size, by End User, 2017-2032 (USD Million)
TABLE 179. Brazil Hydrolase Market Size, 2017-2032 (USD Million)
TABLE 180. Brazil Hydrolase Market Size, by Enzyme Type, 2017-2032 (USD Million)
TABLE 181. Brazil Hydrolase Market Size, by Source / Production Method, 2017-2032 (USD Million)
TABLE 182. Brazil Hydrolase Market Size, by Formulation and Form, 2017-2032 (USD Million)
TABLE 183. Brazil Hydrolase Market Size, by Application, 2017-2032 (USD Million)
TABLE 184. Brazil Hydrolase Market Size, by Pharmaceuticals and healthcare, 2017-2032 (USD Million)
TABLE 185. Brazil Hydrolase Market Size, by End User, 2017-2032 (USD Million)
TABLE 186. United Kingdom Hydrolase Market Size, 2017-2032 (USD Million)
TABLE 187. United Kingdom Hydrolase Market Size, by Enzyme Type, 2017-2032 (USD Million)
TABLE 188. United Kingdom Hydrolase Market Size, by Source / Production Method, 2017-2032 (USD Million)
TABLE 189. United Kingdom Hydrolase Market Size, by Formulation and Form, 2017-2032 (USD Million)
TABLE 190. United Kingdom Hydrolase Market Size, by Application, 2017-2032 (USD Million)
TABLE 191. United Kingdom Hydrolase Market Size, by Pharmaceuticals and healthcare, 2017-2032 (USD Million)
TABLE 192. United Kingdom Hydrolase Market Size, by End User, 2017-2032 (USD Million)
TABLE 193. Germany Hydrolase Market Size, 2017-2032 (USD Million)
TABLE 194. Germany Hydrolase Market Size, by Enzyme Type, 2017-2032 (USD Million)
TABLE 195. Germany Hydrolase Market Size, by Source / Production Method, 2017-2032 (USD Million)
TABLE 196. Germany Hydrolase Market Size, by Formulation and Form, 2017-2032 (USD Million)
TABLE 197. Germany Hydrolase Market Size, by Application, 2017-2032 (USD Million)
TABLE 198. Germany Hydrolase Market Size, by Pharmaceuticals and healthcare, 2017-2032 (USD Million)
TABLE 199. Germany Hydrolase Market Size, by End User, 2017-2032 (USD Million)
TABLE 200. France Hydrolase Market Size, 2017-2032 (USD Million)
TABLE 201. France Hydrolase Market Size, by Enzyme Type, 2017-2032 (USD Million)
TABLE 202. France Hydrolase Market Size, by Source / Production Method, 2017-2032 (USD Million)
TABLE 203. France Hydrolase Market Size, by Formulation and Form, 2017-2032 (USD Million)
TABLE 204. France Hydrolase Market Size, by Application, 2017-2032 (USD Million)
TABLE 205. France Hydrolase Market Size, by Pharmaceuticals and healthcare, 2017-2032 (USD Million)
TABLE 206. France Hydrolase Market Size, by End User, 2017-2032 (USD Million)
TABLE 207. Russia Hydrolase Market Size, 2017-2032 (USD Million)
TABLE 208. Russia Hydrolase Market Size, by Enzyme Type, 2017-2032 (USD Million)
TABLE 209. Russia Hydrolase Market Size, by Source / Production Method, 2017-2032 (USD Million)
TABLE 210. Russia Hydrolase Market Size, by Formulation and Form, 2017-2032 (USD Million)
TABLE 211. Russia Hydrolase Market Size, by Application, 2017-2032 (USD Million)
TABLE 212. Russia Hydrolase Market Size, by Pharmaceuticals and healthcare, 2017-2032 (USD Million)
TABLE 213. Russia Hydrolase Market Size, by End User, 2017-2032 (USD Million)
TABLE 214. Italy Hydrolase Market Size, 2017-2032 (USD Million)
TABLE 215. Italy Hydrolase Market Size, by Enzyme Type, 2017-2032 (USD Million)
TABLE 216. Italy Hydrolase Market Size, by Source / Production Method, 2017-2032 (USD Million)
TABLE 217. Italy Hydrolase Market Size, by Formulation and Form, 2017-2032 (USD Million)
TABLE 218. Italy Hydrolase Market Size, by Application, 2017-2032 (USD Million)
TABLE 219. Italy Hydrolase Market Size, by Pharmaceuticals and healthcare, 2017-2032 (USD Million)
TABLE 220. Italy Hydrolase Market Size, by End User, 2017-2032 (USD Million)
TABLE 221. Spain Hydrolase Market Size, 2017-2032 (USD Million)
TABLE 222. Spain Hydrolase Market Size, by Enzyme Type, 2017-2032 (USD Million)
TABLE 223. Spain Hydrolase Market Size, by Source / Production Method, 2017-2032 (USD Million)
TABLE 224. Spain Hydrolase Market Size, by Formulation and Form, 2017-2032 (USD Million)
TABLE 225. Spain Hydrolase Market Size, by Application, 2017-2032 (USD Million)
TABLE 226. Spain Hydrolase Market Size, by Pharmaceuticals and healthcare, 2017-2032 (USD Million)
TABLE 227. Spain Hydrolase Market Size, by End User, 2017-2032 (USD Million)
TABLE 228. China Hydrolase Market Size, 2017-2032 (USD Million)
TABLE 229. China Hydrolase Market Size, by Enzyme Type, 2017-2032 (USD Million)
TABLE 230. China Hydrolase Market Size, by Source / Production Method, 2017-2032 (USD Million)
TABLE 231. China Hydrolase Market Size, by Formulation and Form, 2017-2032 (USD Million)
TABLE 232. China Hydrolase Market Size, by Application, 2017-2032 (USD Million)
TABLE 233. China Hydrolase Market Size, by Pharmaceuticals and healthcare, 2017-2032 (USD Million)
TABLE 234. China Hydrolase Market Size, by End User, 2017-2032 (USD Million)
TABLE 235. India Hydrolase Market Size, 2017-2032 (USD Million)
TABLE 236. India Hydrolase Market Size, by Enzyme Type, 2017-2032 (USD Million)
TABLE 237. India Hydrolase Market Size, by Source / Production Method, 2017-2032 (USD Million)
TABLE 238. India Hydrolase Market Size, by Formulation and Form, 2017-2032 (USD Million)
TABLE 239. India Hydrolase Market Size, by Application, 2017-2032 (USD Million)
TABLE 240. India Hydrolase Market Size, by Pharmaceuticals and healthcare, 2017-2032 (USD Million)
TABLE 241. India Hydrolase Market Size, by End User, 2017-2032 (USD Million)
TABLE 242. Japan Hydrolase Market Size, 2017-2032 (USD Million)
TABLE 243. Japan Hydrolase Market Size, by Enzyme Type, 2017-2032 (USD Million)
TABLE 244. Japan Hydrolase Market Size, by Source / Production Method, 2017-2032 (USD Million)
TABLE 245. Japan Hydrolase Market Size, by Formulation and Form, 2017-2032 (USD Million)
TABLE 246. Japan Hydrolase Market Size, by Application, 2017-2032 (USD Million)
TABLE 247. Japan Hydrolase Market Size, by Pharmaceuticals and healthcare, 2017-2032 (USD Million)
TABLE 248. Japan Hydrolase Market Size, by End User, 2017-2032 (USD Million)
TABLE 249. Australia Hydrolase Market Size, 2017-2032 (USD Million)
TABLE 250. Australia Hydrolase Market Size, by Enzyme Type, 2017-2032 (USD Million)
TABLE 251. Australia Hydrolase Market Size, by Source / Production Method, 2017-2032 (USD Million)
TABLE 252. Australia Hydrolase Market Size, by Formulation and Form, 2017-2032 (USD Million)
TABLE 253. Australia Hydrolase Market Size, by Application, 2017-2032 (USD Million)
TABLE 254. Australia Hydrolase Market Size, by Pharmaceuticals and healthcare, 2017-2032 (USD Million)
TABLE 255. Australia Hydrolase Market Size, by End User, 2017-2032 (USD Million)
TABLE 256. South Korea Hydrolase Market Size, 2017-2032 (USD Million)
TABLE 257. South Korea Hydrolase Market Size, by Enzyme Type, 2017-2032 (USD Million)
TABLE 258. South Korea Hydrolase Market Size, by Source / Production Method, 2017-2032 (USD Million)
TABLE 259. South Korea Hydrolase Market Size, by Formulation and Form, 2017-2032 (USD Million)
TABLE 260. South Korea Hydrolase Market Size, by Application, 2017-2032 (USD Million)
TABLE 261. South Korea Hydrolase Market Size, by Pharmaceuticals and healthcare, 2017-2032 (USD Million)
TABLE 262. South Korea Hydrolase Market Size, by End User, 2017-2032 (USD Million)
TABLE 263. Global Hydrolase Market Share, by Key Player, 2025
TABLE 264. Global Hydrolase Market, Key Experts

Companies Mentioned

  • AB Enzymes GmbH
  • ABF Ingredients
  • Advanced Enzyme Technologies Ltd.
  • Amano Enzyme Inc.
  • Archer‑Daniel Midland Company
  • AstraZeneca plc
  • BASF SE
  • Bayer AG
  • Chr. Hansen Holding A/S
  • DSM N.V.
  • DuPont de Nemours, Inc.
  • Enzyme Development Corporation
  • Genencor
  • GlaxoSmithKline plc
  • Hangzhou Tianyuan Biochemical Co., Ltd.
  • InVitro International LLC
  • Kerry Group plc
  • Kingenta Ecological Engineering Group Co., Ltd.
  • Novozymes A/S
  • Novus International, Inc.
  • Pfizer Inc.
  • Puratos Group NV
  • Shandong Longda Biotechnology Co., Ltd.
  • Syngenta AG
  • Tate & Lyle PLC